Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych MEQs / SAQsChild and adolescent psychiatry — neurodevelopmental

Psych MEQs / SAQs · Child and adolescent psychiatry — neurodevelopmental

Autism spectrum disorder — assessment to irritability management (MEQ)

FRANZCP-style MEQ on ASD criteria, differentials, early intervention evidence, irritability pharmacotherapy with monitoring, and transition/capacity framing.

20 marks20 min1 min readVerification in progress

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 7-year-old boy with longstanding social-communication difficulties, intense interest in train timetables, and distress at minor routine changes is brought after 3 months of daily aggression and self-hitting causing bruising. School describes meltdowns when plans change. Hearing was normal at age 3; no seizures. He meets clinical criteria for ASD. (i) State the DSM-5-TR structure required for ASD and how severity is rated. (ii) Outline key differentials from ADHD, intellectual disability, social anxiety and social (pragmatic) communication disorder with discriminators. (iii) Describe the non-pharmacological package and name at least two landmark intervention trials. (iv) Indicate when risperidone or aripiprazole would be considered, with a named starting approach, monitoring and an evidence landmark for each class of agent. (v) List capacity/transition issues you would anticipate for later adolescence. (20 marks)

Model answer

Reveal model answerShowHide

(i) Criteria and severity. ASD requires persistent deficits in all three social-communication domains (reciprocity; nonverbal communicative behaviour; relationships) and at least two of four RRB domains (stereotypies/repetitive speech or object use; insistence on sameness; restricted interests; sensory hyper/hyporeactivity), early developmental onset, impairment, and not better explained by intellectual disability alone. Rate severity separately for social communication and RRBs as Level 1–3 support need.[1]

(ii) Differentials. ADHD: inattention/impulsivity core; social interest often present; high co-occurrence. ID alone: social skills roughly match developmental level; ASD requires deficit beyond developmental expectation. Social anxiety: fear of scrutiny with skills often intact when comfortable. SCD: social language deficits without RRBs. This child has RRBs (timetables, sameness distress) → ASD not SCD.[1]

(iii) Non-drug package. Educational adjustments, speech/OT, structured behavioural supports, parent training, and early developmental intervention. Name ESDM (Dawson RCT) and PACT (Green parent-mediated RCT); Bearss parent training for disruptive behaviour outperforms education alone.[4][5][6]

(iv) Irritability medicines. After functional analysis, medical pain screen and behavioural optimisation, severe ongoing aggression/self-injury may justify risperidone (RUPP/McCracken: low weight-based start e.g. about 0.25–0.5 mg/day with slow titration; monitor weight, metabolic panel, EPS, prolactin) or aripiprazole (Owen: start commonly 2 mg daily, titrate toward trial effective range; monitor metabolic effects and akathisia). Neither treats core social deficits. Review for dose minimisation once stable.[2][3]

(v) Capacity and transition. Decision-specific capacity with supported decision-making; least restrictive care under local law. From mid-teens plan CAMHS-to-adult transition: written care plan, education/employment, medication review, housing, safeguarding against exploitation, and adult mental health follow-up for comorbidity risk.[1]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this meqs / saq. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Hyman SL, Levy SE, Myers SM Identification, Evaluation, and Management of Children With Autism Spectrum Disorder Pediatrics, 2020.PMID 31843864
  2. [2]McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems N Engl J Med, 2002.PMID 12151468
  3. [3]Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder Pediatrics, 2009.PMID 19948625
  4. [4]Dawson G, Rogers S, Munson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model Pediatrics, 2010.PMID 19948568
  5. [5]Green J, Charman T, McConachie H, et al. Parent-mediated communication-focused treatment in children with autism (PACT): a randomised controlled trial Lancet, 2010.PMID 20494434
  6. [6]Bearss K, Johnson C, Smith T, et al. Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial JAMA, 2015.PMID 25898050
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousADHD across the lifespan — assessment and multimodal management (MEQ)Child and adolescent psychiatry — neurodevelopmentalNextLanguage and communication disorders — DLD, SPCD and SLT-first care (MEQ)Child and adolescent psychiatry — neurodevelopmental